01 12ASTRAZENECA
01 28425934
02 410300065
03 210300065*PED
04 28425934*PED
05 2RE46276*PED
01 12Blank
01 2Y
02 10Blank
01 22025-04-30
02 22030-04-17
03 22030-10-17
04 42036-01-27
05 22036-07-27
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2541
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2541
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2542
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2542
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2030-04-17
US Patent Number : 8425934
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-04-17
Patent Expiration Date : 2030-04-17
US Patent Number : 8425934
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-04-17
Patent Expiration Date : 2030-10-17
US Patent Number : 8425934*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-17
Patent Expiration Date : 2030-10-17
US Patent Number : 8425934*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-17
Patent Expiration Date : 2025-04-30
US Patent Number : RE46276*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-30
Patent Expiration Date : 2025-04-30
US Patent Number : RE46276*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-30
